[HTML][HTML] CD39 inhibition and VISTA blockade may overcome radiotherapy resistance by targeting exhausted CD8+ T cells and immunosuppressive myeloid cells
Y Zhang, J Hu, K Ji, S Jiang, Y Dong, L Sun, J Wang… - Cell Reports …, 2023 - cell.com
Although radiotherapy (RT) has achieved great success in the treatment of non-small cell
lung cancer (NSCLC), local relapses still occur and abscopal effects are rarely seen even …
lung cancer (NSCLC), local relapses still occur and abscopal effects are rarely seen even …
CD39 inhibition and VISTA blockade may overcome radiotherapy resistance by targeting exhausted CD8+ T cells and immunosuppressive myeloid cells
Y Zhang, J Hu, K Ji, S Jiang, Y Dong… - Cell reports …, 2023 - pubmed.ncbi.nlm.nih.gov
Although radiotherapy (RT) has achieved great success in the treatment of non-small cell
lung cancer (NSCLC), local relapses still occur and abscopal effects are rarely seen even …
lung cancer (NSCLC), local relapses still occur and abscopal effects are rarely seen even …
[HTML][HTML] CD39 inhibition and VISTA blockade may overcome radiotherapy resistance by targeting exhausted CD8+ T cells and immunosuppressive myeloid cells
Y Zhang, J Hu, K Ji, S Jiang, Y Dong, L Sun, J Wang… - Cell Reports …, 2023 - Elsevier
Although radiotherapy (RT) has achieved great success in the treatment of non-small cell
lung cancer (NSCLC), local relapses still occur and abscopal effects are rarely seen even …
lung cancer (NSCLC), local relapses still occur and abscopal effects are rarely seen even …
[HTML][HTML] CD39 inhibition and VISTA blockade may overcome radiotherapy resistance by targeting exhausted CD8+ T cells and immunosuppressive myeloid cells
Y Zhang, J Hu, K Ji, S Jiang, Y Dong, L Sun… - Cell Reports …, 2023 - ncbi.nlm.nih.gov
Although radiotherapy (RT) has achieved great success in the treatment of non-small cell
lung cancer (NSCLC), local relapses still occur and abscopal effects are rarely seen even …
lung cancer (NSCLC), local relapses still occur and abscopal effects are rarely seen even …
CD39 inhibition and VISTA blockade may overcome radiotherapy resistance by targeting exhausted CD8+ T cells and immunosuppressive myeloid cells.
Y Zhang, J Hu, K Ji, S Jiang, Y Dong, L Sun… - Cell reports …, 2023 - europepmc.org
CD39 inhibition and VISTA blockade may overcome radiotherapy resistance by targeting
exhausted CD8+ T cells and immunosuppressive myeloid cells. - Abstract - Europe PMC Sign …
exhausted CD8+ T cells and immunosuppressive myeloid cells. - Abstract - Europe PMC Sign …
[引用][C] CD39 inhibition and VISTA blockade may overcome radiotherapy resistance by targeting exhausted CD8+ T cells and immunosuppressive myeloid cells
Y Zhang, J Hu, K Ji, S Jiang, Y Dong, L Sun, J Wang… - Cell Reports, 2023 - europepmc.org
Although radiotherapy (RT) has achieved great success in the treatment of non-small cell
lung cancer (NSCLC), local relapses still occur and abscopal effects are rarely seen even …
lung cancer (NSCLC), local relapses still occur and abscopal effects are rarely seen even …